acampros alcohol intak wean alcohol hundr sixty-nin alcohol double-blind placebo-control multicent studi effect acampros calcium acetylhomotaurin CA g/day indic alcohol relaps withdraw eighty-on patient CA group placebo group three-month studi major efficaci criterion plasma gamma-glutamyl transpeptidas ggt indic recent alcohol ingest analysi criteria concord analysi number indic alcohol intak patient group similar month treatment patient CA group ggt versu time normal signific differ trend favor superior effect CA placebo major side-effect CA present CA patient placebo CA superior evolut marker alcohol ingest month large-scal multicent studi new modal drug therapi alcohol antabus effect antidepress action condit 